Bibliography of the Literatures on Tuberculosis, TB/HIV and MDRTB in Ethiopia from 2001 – 2017

Ethiopia is among the thirty-high tuberculosis (TB) burden countries with multidrug resistant tuberculosis (MDR-TB) and Tuberculosis/Human Immunodeficiency Virus (TB/HIV). Given the public health importance of the problem, it is apparent that probing the work done in this regard is essential to mitigate the problem and thus we reviewed research repositories and compile directories of researches in Ethiopia from Jan 1, 2001 to Dec 30, 2017 in order to avail evidence-based information to stakeholders and beneficiaries intervening the problem in the country. The evidences generated in this bibliography are through different databases and websites using key terms. A range of different published and unpublished literatures (journal articles, conference presentations, reports/manual/book, and graduate theses or dissertations) on TB, MDR-TB, extensively drug resistant TB (XDR-TB), or TB/HIV are presented. We presented literatures by four themes (Biomedical and clinical researches, epidemiological researches, operational or implementation researches, and health systems researches). A total of 1571 researches and reports were accessed through the above search engines and revealed 635 epidemiological researches followed by 538 clinical or biomedical researches, 257 operational or implementation research, and 141 health systems research. Interestingly, up to 2008 clinical or biomedical researchers were the leading researches and from 2009 onwards, epidemiological researches held the largest constituency. In conclusion, TB or TB/HIV and MDR-TB literatures in Ethiopia have substantially increased over years. Referred journal publications took theleading source and epidemiologic studies were the commonest one. We suggest the need to focus on operational or implementation and health system researches to plummet the disease spreading, drug resistance and impact. We also recommend a regular update of the bibliography every 3 to 4 years with annotations

ANALISIS SURVIVAL PADA PASIEN TB-MDR (MULTI-DRUG RESISTANT TUBERCULOSIS) DI PROVINSI SUMATERA UTARA TAHUN 2020- 2022

Tujuan Tingkat keparahan TB-MDR menyebabkan penyakit ini menjadi epidemi di berbagai negara. WHO juga sudah mencanangkan program internasional “End TB” yang sampai saat ini belum mencapai setengah target. Indonesia sudah menempati posisi ke-tiga terttinggi setelah India dan China dengan CFR sebesar 0,11% dan Provinsi Sumatera Utara sudah berada ditingkat ke-6 tertinggi di Indonesia dan tertinggi di Pulau Sumatera. Tujuan dari penelitian ini adalah untuk melihat survival pasien TB-MDR di Provinsi Sumatera Utara. Metode Penelitian ini menggunakan desain cohort retrospektif dengan data sekunder kasus TB-MDR tahun 2020 – 2022. Sampel yang digunakan adalah sampling yang memenuhi kriteria sampel, data lengkap dan sudah keluar hasil pengobatannya. Analisis yang dilakukan analisis univariat, kaplan-meier, bivariat menggunakan logrank test dan multivariat dengan regresi logistik full model. Hasil Didapatkan dari total 664 terdapat (26,81%) meninggal dan (73,19%) yang masih bertahan hidup. Adapun variabel yang berhubungan dengan survival pada pasien TB-MDR yaitu umur (p = 0,000 HR(Hazard Ratio) 1,88) dan variabel status HIV (p = 0,001 HR 1,40). Variabel yang dominan berhubungan dengan survival adalah umur (p = 0,000 HR 0,64). Kesimpulan Umur dan status HIV memiliki hubungan yang signifikan dengan survival, sementara jenis kelamin, resistensi OAT, riwayat DM, riwayat pengobatan dan keterlambatan pengobatan tidak memiliki hubungan signifikan. Saran agar pasien, keluarga pasien dengan usia ≥ 41 untuk lebih memperhatikan kondisi kesehatan dengan cara rutin memeriksakan diri ke pusat layanan kesehatan maupun dengan gaya hidup sehat, rutin mengonsumsi makanan sehat, istirahat cukup dan olahraga

Emerging infectious diseases

Emerging Infectious Diseases is providing access to these abstracts on behalf of the ICEID 2008 program committee, which performed peer review. Emerging Infectious Diseases has not edited or proofread these materials and is not responsible for inaccuracies or omissions. All information is subject to change.Comments and corrections should be brought to the attention of the authors.Slide Sessions -- Foodborne & waterborne diseases I -- Influenza I -- Surveillance: International -- Zoonotic & animal diseases I -- Methicillin-resistant stapylococcal infections -- Vectorborne diseases -- Foodborne & waterborne diseases II -- Influenza II -- Surveillance: Domestic -- Zoonotic & animal diseases II -- Noscomial infections -- Respiratory diseases -- Health communications -- Blood, organ, & tissue safety -- Tropical diseases -- New rapid diagnostics -- Mobile populations & infectious diseases -- Vaccine-preventable diseases -- Tuberculosis -- Sexually transmitted diseases -- -- Poster Abstracts -- Vaccines & vaccine-preventable diseases -- Antimicrobial resistance -- Climate changes -- Foodborne & waterborne infections -- Health communication -- Infectious causes of chronic diseases -- Influenza -- New or rapid diagnostics -- Nosocomial infections -- Outbreak investigation: Lab & epi response -- Sexually transmitted diseases -- Surveillance: International & new strategies -- Travelers' health & disease importation -- Tropical infections & parasitic diseases -- Vector-borne diseases -- Women, gender, sexual minorities & infectious diseases -- Zoonotic & animal diseases -- Vaccines & vaccine-preventable diseases -- Antimicrobial resistance -- Emerging aspects of HIV -- Foodborne & waterborne infections -- Health communication -- Molecular epidemiology -- Outbreak investigation: Lab & epi response -- Poverty & infectious diseases -- Surveillance: International & new strategies -- Tropical infections & parasitic diseases -- Vector-borne diseases -- Zoonotic & animal diseases -- Vaccines & vaccine-preventable diseases -- Antimicrobial resistance -- Blood, organ, & other tissue safety -- Foodborne & waterborne infections -- Host & microbial genetics -- Influenza -- Molecular epidemiology -- New or rapid diagnostics -- Outbreak investigation: Lab & epi response -- Prevention effectiveness, cost effectiveness, & cost studies -- Surveillance: International & new strategies -- Vector-borne diseases -- Zoonotic & animal diseases -- Vaccines & vaccine-preventable diseases -- Antimicrobial resistance -- Bioterrorism preparedness -- Emerging opportunistic infections -- Foodborne & waterborne infections -- Healthcare worker safety -- Influenza -- Laboratory proficiency testing/quality assurance -- Modeling -- Nosocomial infections -- Outbreak investigation: Lab & epi response -- Vector-borne diseases -- Viral hepatitis -- Zoonotic & animal diseases -- Vaccines & vaccine-preventable diseases -- Antimicrobial resistance -- Emerging opportunistic infections -- Foodborne & waterborne infections -- Influenza -- New or rapid diagnostics -- Nosocomial infections -- Outbreak investigation: Lab & epi response -- Social determinants of infectious disease disparities -- Surveillance: International & new strategies -- Tuberculosis -- Vector-borne diseases -- Zoonotic & animal diseases -- -- Additional Poster Abstracts.Abstracts published in advance of the conference